Gabriele De Marco
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Two patterns of sacroiliac joint bone marrow oedema are apparent in AxSpA determined by HLA-B27 status, body mass index or psoriasis.
Journal: Joint bone spine
Published: March 28, 2026
Long-term treatment transition patterns after intensive treatment strategies in early psoriatic arthritis: insights from the GOLMePsA clinical trial.
Journal: The Lancet. Rheumatology
Published: February 03, 2026
DNA hypo-methylation of the TNFΑ gene predicts response to methotrexate in rheumatoid arthritis but not in psoriatic arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 17, 2025
Beyond the scales: time to prioritise treatment of obesity in psoriatic disease.
Journal: Annals of the rheumatic diseases
Published: November 12, 2025
Whole body-MRI identifies widespread, low intensity inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve, active PsA: data from the GOLMePsA clinical trial.
Journal: Rheumatology (Oxford, England)
Published: November 12, 2025
PASDAS test-retest reliability in early, untreated PsA: data from the GOLMePsA clinical trial.
Journal: Rheumatology (Oxford, England)
Published: September 21, 2025
Are investigator-initiated clinical trials becoming an 'endangered species'?
Journal: RMD open
Published: September 04, 2025
Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.
Journal: Rheumatology (Oxford, England)
Published: August 20, 2025
How Should We Count the Toe Joints in the 66/68 Joint Count in Psoriatic Arthritis? Results of an International Survey.
Journal: The Journal of rheumatology
Published: April 15, 2025
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral route.
Journal: Rheumatology advances in practice
Published: April 14, 2025
Late-Onset Spondyloarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin -17 Blockade May Have a Therapeutic Role.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 08, 2025
Last Updated: 09/26/2026